Oncolytics Biotech (ONCY) Depreciation & Amortization - Total (2024 - 2025)
Oncolytics Biotech's (ONCY) quarterly Depreciation & Amortization - Total came in at $17.44 in Q3 2025, down 33.92% year-on-year from $26.39 in Q3 2024, and down 33.92% on a QoQ basis from $26.39 in Q3 2024.
Oncolytics Biotech (ONCY) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 2 years of Depreciation & Amortization - Total data on file, last reported at $17.44 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.44 |
| Sep 30, 2024 | 26.39 |